Randomized trial of early corticosteroid reduction vs. regular-dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: The Brazilian CORRETA trial

Clinical Transplantation

Volumn 24, Issue 4, 2010, Pages

  Garcia, Valter D ^a   Carvalho, Deise B M ^b   Gonçalves, Renato T ^c   Cavalcanti, Ruy L ^d   Campos, Henry H ^e   Abbud Filho, Mário ^f   Lobao Neto, Abner A ^g  

^a Renal and Pancreas Transplant Unit   (Brazil)

^b HOSPITAL GERAL DE BONSUCESSO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^f HOSPITAL DE BASE   (Brazil)

^g Janssen Cilag Brazil   (Brazil)

Author keywords

Glucocorticoids; Immunosuppression; Kidney transplantation; Mycophenolate mofetil; Tacrolimus

Indexed keywords

INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL ANTIDIABETIC AGENT; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVING DONOR; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY;

ADOLESCENT; ADULT; AGED; BRAZIL; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; TIME FACTORS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955760154     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01185.x     Document Type: Article

References (21)

1. Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005, 5:843.
2. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994, 331:365.
3. Woodle ES, Buell J, Siegel C, Kulkarni S, Kopelan A, Grewal HP. Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplant Proc 1999, 31:84S.
4. Hricik DE, Whalen CC, Lautman J. Withdrawal of steroids after renal transplantation--clinical predictors of outcome. Transplantation 1992, 53:41.
5. Grewal HP, Thistlethwaite JR, Loss GE. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc 1998, 30:1378.
6. Ringe B, Braun F, Wietzke P, Oellerich M, Ramadori G. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. Transplant Proc 2000, 32:2543.
7. Woodle ES. A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report. Transplant Proc 2005, 37:804.
8. Racusen LC, Solez K, Colvin RB. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713.
9. Solez K, Benediktsson H, Cavallo T. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996, 28:441.
10. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837.
11. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1998, 84:985.
12. Smak Gregoor PJ, de Sevaux RG, Ligtenberg G. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol 2002, 13:1365.
13. Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clin Transplant 2007, 21:101.
14. Gallon L, Perico N, Dimitrov BD. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 2006, 6:1617.
15. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993, 4:1300.
16. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000, 11:1910.
17. Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004, 78:1548.
18. Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005 Oct 19, (4).
19. Wlodarczyk Z, Walaszewski J, Perner F. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Transpl Int 2005, 18:157.
20. Anil Kumar MS, Heifets M, Fyfe B. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 2005, 80:807.
21. Laftavi MR, Stephan R, Stefanick B. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 2005, 137:364.